Literature DB >> 23689652

Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI).

Peter A McCullough1, Josee Bouchard, Sushrut S Waikar, Edward D Siew, Zoltan H Endre, Stuart L Goldstein, Jay L Koyner, Etienne Macedo, Kent Doi, Salvatore Di Somma, Andrew Lewington, Ravi Thadhani, Raj Chakravarthi, Can Ice, Mark D Okusa, Jacques Duranteau, Peter Doran, Li Yang, Bertrand L Jaber, Shane Meehan, John A Kellum, Michael Haase, Patrick T Murray, Dinna Cruz, Alan Maisel, Sean M Bagshaw, Lakhmir S Chawla, Ravindra L Mehta, Andrew D Shaw, Claudio Ronco.   

Abstract

Detection of acute kidney injury is undergoing a dynamic revolution of biomarker technology allowing greater, earlier, and more accurate determination of diagnosis, prognosis, and with powerful implication for management. Biomarkers can be broadly considered as any measurable biologic entity or process that allows differentiation between normal function and injury or disease. The ADQI (Acute Dialysis Quality Initiative) had its Ninth Consensus Conference dedicated to synthesis and formulation of the existing literature on biomarkers for the detection of acute kidney injury in a variety of settings. In the papers that accompany this summary, ADQI workgroups fully develop key concepts from a summary of the literature in the domains of early diagnosis, differential diagnosis, prognosis and management, and concurrent physiologic and imaging measures.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689652      PMCID: PMC3856225          DOI: 10.1159/000349962

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  13 in total

Review 1.  Acute kidney injury: definition, epidemiology, and outcome.

Authors:  Nattachai Srisawat; John A Kellum
Journal:  Curr Opin Crit Care       Date:  2011-12       Impact factor: 3.687

Review 2.  CT angiography of the renal circulation.

Authors:  Peter S Liu; Joel F Platt
Journal:  Radiol Clin North Am       Date:  2010-03       Impact factor: 2.303

3.  Acute Dialysis Quality Initiative (ADQI): methodology.

Authors:  J A Kellum; R Bellomo; C Ronco
Journal:  Int J Artif Organs       Date:  2008-02       Impact factor: 1.595

4.  Multimodality prevention of contrast-induced acute kidney injury.

Authors:  Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2008-02       Impact factor: 8.860

Review 5.  Biomarkers of kidney injury.

Authors:  Anja Urbschat; Nicholas Obermüller; Axel Haferkamp
Journal:  Biomarkers       Date:  2011-07       Impact factor: 2.658

6.  Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.

Authors:  Kent Doi; Kousuke Negishi; Tomoko Ishizu; Daisuke Katagiri; Toshiro Fujita; Takehiro Matsubara; Naoki Yahagi; Takeshi Sugaya; Eisei Noiri
Journal:  Crit Care Med       Date:  2011-11       Impact factor: 7.598

Review 7.  Metabolomics for early detection of drug-induced kidney injury: review of the current status.

Authors:  Kurt J Boudonck; Donald J Rose; Edward D Karoly; Douglas P Lee; Kay A Lawton; Paula J Lapinskas
Journal:  Bioanalysis       Date:  2009-12       Impact factor: 2.681

8.  An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Donna Goldsmith; Samantha Bates; Claudio Ronco
Journal:  Crit Care Med       Date:  2006-07       Impact factor: 7.598

Review 9.  Flow-mediated vasodilation as a diagnostic modality for vascular failure.

Authors:  Teruo Inoue; Hidehiro Matsuoka; Yukihito Higashi; Shin-Ichiro Ueda; Masataka Sata; Ken-Ei Shimada; Yutaka Ishibashi; Koichi Node
Journal:  Hypertens Res       Date:  2008-12       Impact factor: 3.872

10.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097

View more
  35 in total

Review 1.  Acute kidney injury-epidemiology, outcomes and economics.

Authors:  Oleksa Rewa; Sean M Bagshaw
Journal:  Nat Rev Nephrol       Date:  2014-01-21       Impact factor: 28.314

2.  Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis.

Authors:  Zoltán H Endre; John W Pickering
Journal:  Nat Rev Nephrol       Date:  2014-10-28       Impact factor: 28.314

3.  Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery.

Authors:  Kenneth E Mah; Shiying Hao; Scott M Sutherland; David M Kwiatkowski; David M Axelrod; Christopher S Almond; Catherine D Krawczeski; Andrew Y Shin
Journal:  Pediatr Nephrol       Date:  2017-11-11       Impact factor: 3.714

4.  Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in Critically Ill Children (AWARE): A Prospective Study to Improve Diagnostic Precision.

Authors:  Rajit K Basu; Ahmad Kaddourah; Tara Terrell; Theresa Mottes; Patricia Arnold; Judd Jacobs; Jennifer Andringa; Melissa Armor; Lauren Hayden; Stuart L Goldstein
Journal:  J Clin Trials       Date:  2015-04-17

5.  Kidney biomarkers in tropical infections: an update.

Authors:  Daniella Bezerra Duarte; Maria Carolina Santa Rita Lacerda; Yara Janaína Porto Ribeiro; Maria Zenaide Dias Ribeiro; Matheus de Almeida Frederico; Michelle Jacintha Cavalcante Oliveira
Journal:  Pathog Glob Health       Date:  2020-07-29       Impact factor: 2.894

Review 6.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

7.  Patients with cardiorenal syndrome revealed increased neurohormonal activity, tubular and myocardial damage compared to heart failure patients with preserved renal function.

Authors:  Alberto Palazzuoli; Gaetano Ruocco; Marco Pellegrini; Simona Martini; Gabriele Del Castillo; Matteo Beltrami; Beatrice Franci; Barbara Lucani; Ranuccio Nuti
Journal:  Cardiorenal Med       Date:  2014-12-10       Impact factor: 2.041

Review 8.  Acute Kidney Injury: Diagnostic Approaches and Controversies.

Authors:  Konstantinos Makris; Loukia Spanou
Journal:  Clin Biochem Rev       Date:  2016-12

Review 9.  Sepsis-associated acute kidney injury.

Authors:  Rashid Alobaidi; Rajit K Basu; Stuart L Goldstein; Sean M Bagshaw
Journal:  Semin Nephrol       Date:  2015-01       Impact factor: 5.299

10.  Novel renal biomarkers show that creatine supplementation is safe: a double-blind, placebo-controlled randomized clinical trial.

Authors:  José de Oliveira Vilar Neto; Carlos Alberto da Silva; Gdayllon Cavalcante Meneses; Daniel Vieira Pinto; Luciana Catunda Brito; Said Goncalves da Cruz Fonseca; Renata de Sousa Alves; Alice Maria Costa Martins; Cláudio de Oliveira Assumpção; Elizabeth De Francesco Daher
Journal:  Toxicol Res (Camb)       Date:  2020-05-13       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.